M5A-IL2 Immunocytokine
N/A
Report date: 2025/07/29 20:00:11
Base Information
Drug NameM5A-IL2 Immunocytokine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer InstituteCity Of Hope National Medical Center
China Registration ClassN/A
Develop Information
Active CompaniesNational Cancer InstituteCity Of Hope National Medical Center
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A